Expression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles
ChemBioChem · 12.11.2026 · 27 (21)
DOI: 10.1002/cbic.70572 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, online erschienen am 30.10.2026. Verfasst von Sarah Dahl und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark. Hauptthemen laut MEDLINE: Polymers, Cytochrome P-450 CYP2D6, Artificial Cells, Lipids. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Fonden, Academy of Finland Center of Excellence Program, Australian Research Council Centre of Excellence in Synthetic Biology.
Abstract (Originalsprache)
Artificial cells with the ability to express functional, biomedically relevant enzymes have long been a goal in the field of bottom‐up synthetic biology. Here, we demonstrate the expression of human cytochrome P450 2D6 (CYP2D6) within the lumen of giant hybrid vesicle‐based artificial cells using a cell‐free protein expression system based on the protozoan Leishmania tarentolae . The vesicle membranes comprise 1,2‐dioleoyl‐ sn ‐glycero‐3‐phosphocholine and amphiphilic block copolymers containing poly(cholesteryl methacrylate‐ co ‐butyl methacrylate) with either poly(galactose methacrylate) (pGalacMA) or poly(carboxyethyl acrylate) as the hydrophilic block. The amount and composition of the block copolymer incorporated into the giant hybrid vesicle membrane altered the artificial cells’ ability to support functional protein expression, likely through changes in membrane properties. In particular, giant hybrid vesicles containing pGalacMA supported production of enzymatically active CYP2D6. Overall, the reported approach advances the development of artificial cells capable of producing functional, biomedically relevant enzymes. Further, the effort highlights complex interplay between polymer properties and performance of biological components in the functional complexity achievable in polymer‐lipid hybrid vesicles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.
- School of Biology and Environmental Science, Queensland University of Technology, Brisbane, Australia.
- Department of Applied Physics, Aalto University School of Science, Espoo, Finland.
ORCID-Profile: Sarah Dahl, Paula De Dios Andres, Grégory Beaune, Jaakko V I Timonen, James Behrendorff, Brigitte Städler
Förderung
- Novo Nordisk Fonden
- Academy of Finland Center of Excellence Program
- Australian Research Council Centre of Excellence in Synthetic Biology
- ARC discovery program grants
- NHMRC Investigator grant
- Knud Højgaards Fond
Zitieren
APA
Dahl, S., De Dios Andres, P., Beaune, G., Timonen, J. V. I., Behrendorff, J., Alexandrov, K., Johnston, W., & Städler, B. (2026). Expression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles. ChemBioChem, 27(21). https://doi.org/10.1002/cbic.70572
Vancouver
Dahl S, De Dios Andres P, Beaune G, Timonen JVI, Behrendorff J, Alexandrov K, et al. Expression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles. ChemBioChem. 2026;27(21). doi:10.1002/cbic.70572
BibTeX
@article{Dahl2026,
author = {Dahl, Sarah and De Dios Andres, Paula and Beaune, Grégory and Timonen, Jaakko V I and Behrendorff, James and Alexandrov, Kirill and Johnston, Wayne and Städler, Brigitte},
title = {Expression of Human CYP2D6 in Artificial Cells Based on Polymer‐Lipid Hybrid Vesicles},
journal = {ChemBioChem},
year = {2026},
volume = {27},
number = {21},
doi = {10.1002/cbic.70572}
}
EUVIMED